Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Revenue

Sinovac Biotech reported an annual revenue of $448.27M, reflecting a -69.97% growth. For the quarter ending December 31, 2023, Sinovac Biotech generated $307.87M in revenue.
Revenue (ttm)
448.27M
Revenue Growth
-69.97%
Price / Sales Ratio
1.44
Revenue / Employee
228.83K
Employees
1,959
Market Cap
464.94M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 448.27M -69.97%
Dec 31, 2022 1.49B -92.30%
Dec 31, 2021 19.37B +3694.36%
Dec 31, 2020 510.62M +107.53%
Dec 31, 2019 246.05M +7.14%
Dec 31, 2018 229.65M +31.72%
Dec 31, 2017 174.35M +140.71%
Dec 31, 2016 72.43M +7.44%
Dec 31, 2015 67.41M +7.12%
Dec 31, 2014 62.93M -12.32%
Dec 31, 2013 71.77M +45.83%
Dec 31, 2012 49.22M -13.42%
Dec 31, 2011 56.84M +70.18%
Dec 31, 2010 33.4M -60.33%
Dec 31, 2009 84.2M +81.08%
Dec 31, 2008 46.5M +38.63%
Dec 31, 2007 33.54M +118.44%
Dec 31, 2006 15.35M +78.38%
Dec 31, 2005 8.61M +33.37%
Dec 31, 2004 6.45M +127.34%
Dec 31, 2003 2.84M +446.75%
Apr 30, 2002 519.24K +63.03%
Apr 30, 2001 318.49K +22665.55%
Apr 30, 2000 1.4K +Infinity%
Apr 30, 1999 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.